Y. Hamada

Large-Scale, Prospective Observational Study of Regorafenib in Japanese Patients with Metastatic Colorectal Cancer in a Real-World Clinical Setting.

T. Nishida, K. Muro, K. Sugihara, 2019, The oncologist.

Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations

E. Van Cutsem, A. Grothey, A. Ohtsu, 2014, Investigational New Drugs.

Safety and efficacy of regorafenib post-marketing surveillance (PMS) in Japanese patients with metastatic colorectal cancer (mCRC).

T. Nishida, K. Muro, K. Sugihara, 2017 .